BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.41 Cr | ₹1.55 Cr | ₹0.70 Cr | ₹0.60 Cr | ₹2.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.41 Cr |
| Mar2024 | ₹1.55 Cr |
| Mar2023 | ₹0.70 Cr |
| Mar2022 | ₹0.60 Cr |
| Mar2021 | ₹2.63 Cr |
How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.41 Cr | Negative | |
| Mar2024 | ₹1.55 Cr | 120.34 | |
| Mar2023 | ₹0.70 Cr | 16.39 | |
| Mar2022 | ₹0.60 Cr | -77.05 | |
| Mar2021 | ₹2.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹121.2 Cr | -2.9% | 12% | -26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹388,680.0 Cr | -2.9% | -8.9% | -3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,817.0 Cr | 1.2% | 4.2% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,297.0 Cr | -1.7% | -3.6% | 27.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,828.0 Cr | 6.8% | 1.3% | 13.2% | Stock Analytics | |
| CIPLA | ₹104,588.0 Cr | 5.4% | 3.1% | -13.6% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.9% |
12% |
-26% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses